Mechanistically, XJ104 mediates protection through T-cell activation and Th1/Th17 polarization, augmenting production of IFN-γ and IL-17, cytokines essential for fungal clearance, as validated in murine candidemia models. The gene discussed is IFNG; the disease is Candidemia.